Apex Healthcare Berhad Toekomstige groei

Future criteriumcontroles 2/6

Apex Healthcare Berhad zal naar verwachting groeien in winst en omzet met respectievelijk 9.4% en 7.5% per jaar. De winst per aandeel zal naar verwachting groeien met 9.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.8% zijn.

Belangrijke informatie

9.4%

Groei van de winst

9.3%

Groei van de winst per aandeel

Pharmaceuticals winstgroei	17.1%
Inkomstengroei	7.5%
Toekomstig rendement op eigen vermogen	11.8%
Dekking van analisten	Low
Laatst bijgewerkt	22 Aug 2024

Recente toekomstige groei-updates

Recent updates

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Aug 28

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apr 19

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Feb 25

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Aug 24

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

May 11

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

Feb 11

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Jan 25

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Jan 07

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Dec 20

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

Dec 05

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Nov 20

Winst- en omzetgroeiprognoses

KLSE:AHEALTH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (MYR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	1,169	112	79	109	4
12/31/2025	1,080	104	75	102	4
12/31/2024	1,018	92	72	85	4
6/30/2024	962	89	10	47	N/A
3/31/2024	939	395	36	63	N/A
12/31/2023	936	398	37	65	N/A
9/30/2023	917	413	57	75	N/A
6/30/2023	913	415	57	76	N/A
3/31/2023	908	109	50	69	N/A
12/31/2022	878	101	40	72	N/A
9/30/2022	855	87	39	70	N/A
6/30/2022	834	74	37	68	N/A
3/31/2022	807	63	37	64	N/A
12/31/2021	771	59	50	62	N/A
9/30/2021	735	53	40	55	N/A
6/30/2021	693	53	46	61	N/A
3/31/2021	685	54	65	80	N/A
12/31/2020	699	56	70	85	N/A
9/30/2020	708	56	72	86	N/A
6/30/2020	719	56	62	76	N/A
3/31/2020	704	56	47	61	N/A
12/31/2019	689	53	54	68	N/A
9/30/2019	681	56	30	56	N/A
6/30/2019	666	56	6	54	N/A
3/31/2019	662	57	-12	45	N/A
12/31/2018	653	59	-22	40	N/A
9/30/2018	642	55	-11	46	N/A
6/30/2018	635	51	7	51	N/A
3/31/2018	634	48	N/A	47	N/A
12/31/2017	620	44	N/A	46	N/A
9/30/2017	612	38	N/A	41	N/A
6/30/2017	597	36	N/A	36	N/A
3/31/2017	588	35	N/A	33	N/A
12/31/2016	581	35	N/A	34	N/A
9/30/2016	571	42	N/A	36	N/A
6/30/2016	557	39	N/A	27	N/A
3/31/2016	534	36	N/A	29	N/A
12/31/2015	527	34	N/A	23	N/A
9/30/2015	516	30	N/A	30	N/A
6/30/2015	510	32	N/A	27	N/A
3/31/2015	508	33	N/A	39	N/A
12/31/2014	499	34	N/A	35	N/A
9/30/2014	482	32	N/A	31	N/A
6/30/2014	461	31	N/A	34	N/A
3/31/2014	443	30	N/A	26	N/A
12/31/2013	418	30	N/A	27	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei AHEALTH ( 9.4% per jaar) ligt boven de spaarquote ( 3.6% ).

Winst versus markt: De winst van AHEALTH ( 9.4% per jaar) zal naar verwachting langzamer groeien dan de markt MY ( 10.3% per jaar).

Hoge groeiwinsten: De winst van AHEALTH zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van AHEALTH ( 7.5% per jaar) zal naar verwachting sneller groeien dan de markt MY ( 6.1% per jaar).

Hoge groei-inkomsten: De omzet van AHEALTH ( 7.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen AHEALTH zal naar verwachting over 3 jaar laag zijn ( 11.8 %).

Apex Healthcare Berhad Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target decreased by 7.3% to RM2.55

Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023

Price target decreased by 7.8% to RM2.58

Price target increased to RM3.21

Price target increased to RM3.07

Price target raised to RM2.60

Recent updates

First half dividend increased to RM0.03

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Upcoming dividend of RM0.23 per share

Full year 2023 earnings: EPS exceeds analyst expectations

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: EPS: RM0.56 (vs RM0.14 in FY 2022)

Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Third quarter 2023 earnings released: EPS: RM0.034 (vs RM0.038 in 3Q 2022)

Upcoming dividend of RM0.025 per share at 2.5% yield

Price target decreased by 7.3% to RM2.55

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023

Price target decreased by 7.8% to RM2.58

Second quarter 2023 earnings released: EPS: RM0.46 (vs RM0.033 in 2Q 2022)

Investor sentiment deteriorates as stock falls 36%

First quarter 2023 earnings released: EPS: RM0.051 (vs RM0.033 in 1Q 2022)

Upcoming dividend of RM0.055 per share at 2.3% yield

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: RM0.21 (vs RM0.13 in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.03 in 3Q 2021)

Insufficient new directors

Upcoming dividend of RM0.03 per share

Second quarter 2022 earnings released: EPS: RM0.05 (vs RM0.027 in 2Q 2021)

Apex Healthcare Berhad Declares an Interim Dividend, Payable on 15 September 2022

Price target increased to RM3.21

Upcoming dividend of RM0.09 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to RM3.07

Insufficient new directors

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Proposes Special Single-Tier Dividend for Financial Year Ended 31 December 2021, Payable on 16 June 2022

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Announces Special Dividend in Respect of the Financial Year Ended 31 December2021, Payable on 16 June 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Third quarter 2021 earnings released: EPS RM0.03 (vs RM0.03 in 3Q 2020)

Upcoming dividend of RM0.025 per share

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Second quarter 2021 earnings released: EPS RM0.027 (vs RM0.028 in 2Q 2020)

Upcoming dividend of RM0.028 per share

First quarter 2021 earnings released: EPS RM0.025 (vs RM0.03 in 1Q 2020)

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?

Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)

Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Revenue and earnings miss expectations

New 90-day low: RM3.32

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

New 90-day high: RM3.78

Apex Healthcare Berhad to Be Deleted from Other OTC

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Third quarter 2020 earnings released: EPS RM0.03

Upcoming Dividend of RM0.017 Per Share